Deva Holding AS | DEVA - 销售毛利

股票价格
59.70
每天变化
-1.15 -1.89%
每月一次
-9.68%
每年
-0.33%
Q1 预测
58.60


金融业
股票价格
TRY
资产
TRY 12.93B
现金及等价物
TRY 775.92M
销售成本
TRY 991.13M
流动资产
TRY 9.13B
流动负债
TRY 6.43B
债务
TRY 5.3B
股息收益率
0.18
EBIT
TRY 820.88M
EBITDA
TRY 882.9M
EPS每股收益
TRY 2.92
股本和储备
TRY 5.79B
销售毛利
TRY 1.32B
债务利息支出
TRY 272.53M
贷款资金
TRY 559.97M
市值
TRY 11.94B
净收入
TRY 583.98M
营业费用
TRY 1.35B
营业利润
TRY 964.87M
普通股股本
TRY 200.02M
PE价格收益
6.55
销售收入
TRY 2.32B
销售和管理费用
TRY 462.26M
贸易债权人
TRY 809.81M
应收帐款人
TRY 3.03B


销售毛利 更改 日
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Avita Medical AUD 14.31M 639K 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Ionis Pharmaceuticals USD 195M 40M 2025-12
IQVIA Holdings USD 1.12B 32M 2025-12
Moderna USD 226M 583M 2025-12
Organon & Co USD 854M 3M 2025-12
Revvity USD 421.66M 47.06M 2025-12
Tectonic Therapeutic USD 0 0 2025-03
Viatris USD 1.15B 223.6M 2025-12
Xeris Pharmaceuticals USD 72.15M 8.77M 2025-12